期刊文献+

针吸细胞块技术在术前乳腺癌分子分型中的应用研究

Application of needle aspiration cell block technique in preoperative molecular typing of breast cancer
原文传递
导出
摘要 目的探讨针吸细胞块技术在术前乳腺癌分子分型中的应用价值。方法选取2020年3月至2022年7月75例乳腺癌患者作为研究对象,所有患者术前均接受针吸细胞块技术检查,并以术后病理组织学及免疫组织化学结果为标准,评价针吸细胞块技术在术前乳腺癌分子分型中的应用价值。应用SPSS 20.0软件对数据进行处理,计量资料符合正态分布的采用(±s)表示,计数资料采用[例(%)]表示,行χ^(2)检验。P<0.05表示差异有统计学意义。结果术前针吸细胞块技术诊断为高度可疑乳腺癌和乳腺癌的75例女性患者,经术后病理组织学检查均证实为乳腺癌,针吸细胞块技术对乳腺癌的诊断准确度为100%。术前针吸细胞块技术与术后病理组织学免疫组织化学结果对比显示,孕激素受体(PR)、雌激素受体(ER)、人表皮生长因子受体2(Her-2)和细胞核增殖抗原(Ki-67)的符合率分别为97.3%(73/75)、98.7%(74/75)、97.3%(73/75)和94.7%(71/75),各分子标记物在乳腺癌细胞块与相应组织中的表达结果差异无统计学意义(P>0.05),且术前针吸细胞块技术与术后病理组织学分子分型总符合率可达96.0%。结论针吸细胞块技术是术前乳腺癌诊断中准确且易行的方法,不仅提高了乳腺癌诊断的准确性,进一步明确了乳腺癌的分子分型,并有助于临床医师术前掌握更准确的乳腺癌生物学特征。 Objective To investigate the application value of needle aspiration cell block technique in preoperative molecular classification of breast cancer.Methods Seventy-five patients with breast cancer from March 2020 to July 2022 were selected as research objects.All patients were examined by needle aspiration cell block technique before surgery,and the application value of needle aspiration cell block technique in preoperative molecular typing of breast cancer was evaluated based on postoperative histopathological and immunohistochemical results.SPSS20.0 software was used to process the data.The measurement data conforming to normal distribution was represented by(±s),and the count data was represented by[n(%)],usingχ^(2) test.P<0.05 indicated statistically significant difference.Results 75 female patients diagnosed with highly suspicious breast cancer and breast cancer by needle aspiration cell block technique before surgery were all confirmed to be breast cancer by postoperative histopathological examination.The accuracy of needle aspiration cell block technique for breast cancer diagnosis was 100%.The comparison of preoperative needle aspiration and postoperative histopathological immunohistochemical results showed that,The coincidence rates of progesterone receptor(PR),estrogen receptor(ER),human epidermal growth factor receptor 2(Her-2)and nuclear proliferation antigen(Ki-67)were 97.3%(73/75),98.7%(74/75),97.3%(73/75)and 94.7%(71/75),respectively.There was no significant difference in the expression of each molecular marker between the breast cancer cell block and the corresponding tissue(P>0.05),and the total coincidence rate of preoperative needle aspiration cell block technique and postoperative histopathological molecular typing reached 96.0%.Conclusion Needle aspiration cell block technique is an accurate and easy method in preoperative diagnosis of breast cancer.It not only improves the accuracy of breast cancer diagnosis,further defines the molecular classification of breast cancer,and helps clinicians to grasp more accurate biological characteristics of breast cancer before surgery.
作者 庞兴华 苑著 Pang Xinghua;Yuan Zhu(Department of General Surgery,Beijing Friendship Hospital Affiliated to Capital Medical University,Beijing 100050,China)
出处 《中华普外科手术学杂志(电子版)》 2023年第3期276-279,共4页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
关键词 乳腺肿瘤 活组织检查 针吸 分子分类 应用价值 Breast Neoplasms Biopsy Needle Molecular Typing Application Value
  • 相关文献

参考文献10

二级参考文献57

  • 1吴晓琴,邹丽,胡慧,钟洁愉,刘晓岭,孙德胜,韦伟.术前超声造影联合细胞学检查判断乳腺癌前哨淋巴结状态122例分析[J].临床外科杂志,2020,0(1):49-52. 被引量:8
  • 2张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 3<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 4Viale G,Regan MM,Maiorano E,et al.Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:BIG 1-98[J].J Clin Oncol,2007,25(25):3846-3852.
  • 5Rhodes A,Jasani B,Balaton AJ,et al.Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas:Correlation with patient age,assay sensitivity,threshold value,and mammographic screening[J].J Clin Pathol,2000,53(9):688-696.
  • 6Zhang Z,Wang J,Skinner KA,et al.Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression[J].Histopathology,2014,65(4):508-516.
  • 7Harvey JM,Clark GM,Osbome CK,et al.Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer[J].J Clin Oncol,1999,17(5):1474-1481.
  • 8Elledge RM,Green S,Pugh R,et al.Estrogen receptor(ER)and progesterone receptor(PgR),by ligand-binding assay compared with ER,PgR and pS2,by immunohistocheniistiy in predicting response to tamoxifen in metastatic breast cancer:A Southwest Oncology Group study[J].Int J Cancer,2000,89?2):111-117.
  • 9Hammond ME,Hayes DF,Dowsett M,et al.American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer[J].J Clin Oncol,2010,28(16):2784-2795.
  • 10Wolff AC,Hammond ME,Schwartz JN,et al.American Society of Clinical Oncology/ College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].J Clin Oncol,2007,25(1):118-145.

共引文献2961

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部